This paper proposes a new class of nonparametric tests for the correct specification of generalized propensity score models. The test procedure is based on two different projection arguments, which lead to test statistics with several appealing properties. They accommodate high-dimensional covariates; are asymptotically invariant to the estimation method used to estimate the nuisance parameters and do not requite estimators to be root-n asymptotically linear; are fully data-driven and do not require tuning parameters, can be written in closed-form, facilitating the implementation of an easy-to-use multiplier bootstrap procedure. We show that our proposed tests are able to detect a broad class of local alternatives converging to the null at the parametric rate. Monte Carlo simulation studies indicate that our double projected tests have much higher power than other tests available in the literature, highlighting their practical appeal.
Introduction
One of the primary goals of many scientific fields is to quantify the effect of an exposure/policy/treatment on a particular outcome of interest. When assignment to treatment is not randomized, groups with different levels of the treatment variable usually differ in important ways other than the observed treatment. Because these differences are many times associated with the outcome variable, ascertaining the causal effect of the treatment requires more sophisticated statistical tools than simple comparison of means. It is in this setting that the propensity score of Rosenbaum and Rubin (1983) and its multi-valued generalizations introduced by Imbens (2000) have been shown to be among the most widely used tools for causal inference.
The propensity score was initially introduce by Rosenbaum and Rubin (1983) to adjust for observable differences between the treatment and comparison groups when treatment is binary; it is defined as the conditional probability of receiving treatment given a vector of pre-treatment covariates. It is now well understood that one can use propensity scores to estimate causal effects through matching, weighting, regression, subclassification or their combinations; see Imbens and Rubin (2015) for a textbook treatment.
In many empirical applications, however, treatments are not binary but multi-valued. In such cases, instead of using the binary propensity score as a tool to estimate causal effects, one can use its multi-valued generalization introduced by Imbens (2000), the generalized propensity score, which is defined as the conditional probability of receiving a specific level of the treatment given a vector of pre-treatment covariates. Similarly to the binary treatment case, the generalized propensity score can be used to estimate multi-valued causal effects through matching, weighting, regression, subclassification or their combinations; see Linden et al. (2016) and Lopez and Gutman (2017) for excellent overviews.
Although these statistical procedures that build on the generalized propensity score are popular, a main concern of these methods is that the generalized propensity score is usually unknown, and therefore has to be estimated. Given the high dimensionality of available pre-treatment covariates and limited sample size, researchers are usually coerced to adopt a parametric model for the generalized propensity score to bypass the "curse of dimensionality". Such a common practice raises the important issue of model misspecifications. Indeed, as illustrated by Linden et al. (2016) , model misspecifications can lead to misleading treatment effect estimates. Thus, in practice, it is recommended to assess if your putative model for the generalized propensity score is correctly specified.
In this paper, we propose new goodness-of-fit tests for parametric generalized propensity score models. The main distinguishing feature of our tests is that they combine two different projections: the first one to reduce the dimensionality of the problem and the second one to eliminate the effect from replacing the unknown parameters of the generalized propensity scores with their estimators.
More specifically, our specification tests build on the dimension-reduction projection introduced by Escanciano (2006) , allowing us to effectively handle situations with moderate number of covariates. Our tests also builds on Neyman (1959) , Bickel et al. (2006) , Escanciano and Goh (2014) , and Sant' Anna and Song (2019) in the sense that we explicitly acknowledge we do not know the "true" correct specification of the generalize propensity score by making use of an orthogonal projection onto the tangent space of nuisance parameters.
By combining these simple but powerful projections, we show that our proposed specification tests for the generalized propensity score (a) do not severely suffer from the "curse of dimensionality" when the vector of pre-treatment covariates is high-dimensional; (b) are fully data-driven and do not require tuning parameters such as bandwidths; (c) do not require estimators to be n 1/2 -asymptotically linear, with n the sample size; and (d) are able to detect a broad class of local alternatives converging to the null at the parametric rate. In order to facilitate its practical implementation, we obtain closed-form expressions for our test statistics, and show that critical values can be computed with the assistance of an easy-to-use multiplier-type bootstrap. To the best of our knowledge, no other (specification) test available in the literature enjoys all these attractive properties (e.g., Escanciano, 2006 , Mora and Moro-Egido, 2008 , Shaikh et al., 2009 , Escanciano and Goh, 2014 , García-Portugués et al., 2014 , Sant'Anna and Song, 2019 , and Kim et al., 2020 . The results of Monte Carlo simulations indicate that these attractive properties translate to tests with excellent finite sample properties, even the dimension of covariates is relatively high. As so, they can be routinely used to assess the reliability of causal inference tools that rely on the generalized propensity score.
The rest of this article is organized as follows. In Section 2 we present the testing framework and introduce our proposed double-projection specification tests. The asymptotic properties of our tests are established in Section 3. In Section 4 we present a detailed description of an easy-to-implement multiplier-bootstrap procedure to compute critical values. We then examine the finite sample properties of our tests via Monte Carlo simulations in Section 5, and an empirical illustration in Section 6. Section 7 concludes. Mathematical proofs and additional simulation results are gathered in an appendix at the end of the article.
2 Generalized propensity scores 2.1 Setup For a generic d 1 × d 2 matrix A, A ⊤ denotes the transpose of A. Let J ∈ N be a given finite positive integer. We consider the potential outcome model of Rubin (1974) . Let (X ⊤ , T, Y ) ⊤ be a random vector in a (d x + 2)-dimensional Euclidean space, where X ∈ X ⊆ R dx is an observable d x × 1 vector of pre-treatment covariates with d x ∈ N, T ∈ T ⊆{0, 1, . . . , J} is the treatment random variable, Y = T t=0 1 (T = t) Y (t) ∈ Y ⊆ R is the observed outcome, and Y (t) denotes the potential outcome when T is externally set to t. For the sake of simplicity, we focus our attention on average causal effects of the form
the average causal effect of exposing units to treatment t rather than treatment s; however we can also cover quantile treatment effects and/or treatment effects for some treated subpopulation (Lee, 2018 , Ao et al., 2019 . Henceforth, we assume that a random sample ment is binary, a common specification for q 1 (X, θ 1 ) is the logistic model q 1 (X, θ 1 ) = exp (X ′ θ 1 ) / (1 + exp (X ′ θ 1 )) (e.g., Rubin, 1983, 1984) . When treatments are multi-valued, qualitatively distinct and without a logical ordering, a popular specification for {q t (x, θ t ) , t ∈ T } is the multinomial logit model (e.g., Imbens, 2000) ,
Finally, when treatments are multi-valued and correspond to ordered levels of treatment such as dosages, a popular model for the treatment allocation T is the ordered logistic model (e.g., McCullagh, 1980 , Joffe and Rosenbaum, 1999 , Lu et al., 2001 , and Uysal, 2015 ,
Researchers then estimate the unknown parameters θ = {θ t , t ∈ T } by maximizing the empirical fit of the generalized propensity score model. This is usually done by maximizing the log-likelihood function:
though we emphasize that alternative estimation procedures can also be used. Armed with a (generic) estimator θ n ≡ θ n,t , t ∈ T , we can proceed to the second step by computing the estimated values for the generalized propensity score, and then use the analogy principle to estimate the average causal effects β(t, s) :
where w t (T, X; θ) = 1 {T = t}/ q t (x, θ) are the inverse probability weights (Hájek, 1971) .
The main practical challenge with the described approach is that the reliability of (4) depends on the model {q t (x, θ t ) , t ∈ T } for the generalized propensity score being correctly specified. Although the aforementioned specifications are popular, they may be too restrictive in some applications. If the working model for the generalized propensity score is misspecified, causal effects estimators such as (4) are in general biased and policy recommendations based on it can be highly misleading (Linden et al., 2016) . To address this issue, in this paper we propose new tests to assess whether the parametric putative model for the generalized propensity score is correctly specified or not; that is, we seek to test
against
where e(t; θ) ≡ 1(T = t) − q t (X, θ) is the parametrically specified generalized error, and Θ ⊂ R q is a compact parametric space with q ≥ 1 a given positive integer.
Specification tests based on double projections
The characterization of H 0 and H 1 in (5) and (6), respectively, makes explicit that testing for whether the putative model for the generalized propensity score is correctly spec-ified or not can be seen as a special case of testing conditional moment restrictions (González-Manteiga and Crujeiras, 2013) . As argued by Escanciano (2006) , (5) can be equivalently characterized as
for some θ * ∈ Θ ⊂ R q and all t ∈ T , (7) where
i.e., S dx = β ∈ R dx : ||β|| = 1 with ||A|| = tr AA ⊤ 1/2 denoting the Euclidean norm for a generic matrix A.
The main motivations of expressing H 0 as in (7) are that (i) R pro t (β, u; θ * ) is based on unconditional moment restrictions, implying that we can avoid the use of tuning parameters such as bandwidths when estimating R pro t (β, u; θ * ); and (ii) R pro t (β, u; θ * ) depends on covariates only through the one-dimensional projection β ⊤ X, greatly reducing the dimensionality of the problem. Indeed, this dimension-reduction device has been proven valuable in many contexts that need to deal with a large number of covariates; see, e.g., Escanciano (2006) , García-Portugués et al. (2014) , Sun et al. (2017) , Zhu et al. (2017) , and Kim et al. (2020) ; for an overview, see Guo and Zhu (2017) . However, it is worth mentioning that (7) involves not only a single process R pro t (β, u; θ * ) as is commonly the case in the specification testing literature (see Escanciano, 2008 for an exception), but J different processes R pro t (β, u; θ * ) associated with the treatment levels t. From (7), one natural way to proceed is to compute the generalized residuals marked empirical process based on the projections 1 β ⊤ X ≤ u ,
where θ n is any √ n-consistent estimator for θ * , say θ mle n defined in (3), and e i (t; θ n ) ≡ 1(T i = t) − q t (X i , θ n ), i = 1, . . . , n, are the parametric generalized residuals under H 0 . Then, one use continuous functionals of R pro n,t to assess if H 0 is rejected or not. A potential drawback of following this path is that the underlying null limiting distribution of R pro n,t (β, u; θ n ) depends on the estimator θ n . Indeed, as we shown in Lemma A.1 in Appendix A, under H 0 and certain regularity conditions including the smoothness of q t (x, θ) with respect to θ and the √ n-consistency behavior of θ n , R pro n,t β, u; θ n can be decomposed as
t ∈ T designates the score function associated with the parametric propensity score model q t (x, θ) at the treatment level t. The asymptotic representation in (8) suggests that, for a given parametric specification p t (x) = q t (x, θ * ), t ∈ T , the asymptotic null distribution of tests based on R pro n,t (β, u; θ n ) will depend on whether one estimates θ * using maximum likelihood, nonlinear least squares, or by the method of estimating equations, even though the underlying specification for the generalized propensity score is the same across these estimation methods. Furthermore, as noted by Escanciano (2006) , tests based on R pro n,t (β, u; θ n ) also require that √ n( θ n − θ * ) admits an asymptotically linear representation. Such a condition can be demanding, especially when one wishes to use estimation methods that involve penalizations (Knight and Fu, 2000, Bühlmann and van de Geer, 2011) .
In light of these potential drawbacks, we follow an alternative route. More specifically, our proposed test statistics are continuous functionals of the generalized residuals marked empirical process based on the double-projections P n,t 1 β ⊤ X ≤ u ,
where the double-projected weight is
We label P n,t 1 β ⊤ X ≤ u as a double-projection because, as it is evident from (9), it involves first using the projection proposed by Escanciano (2006) , 1 β ⊤ X ≤ u , and then projecting 1 β ⊤ X ≤ u onto the the tangent space of the nuisance parameters θ n Goh, 2014, Sant'Anna and Song, 2019) . To the best of our knowledge, this paper is the first to incorporate this double-projection argument, which, in practice, translates to test statistics that are robust against the "curse of dimensionality" and whose limiting null distributions are asymptotically invariant to θ n since, for each t ∈ T ,
with ∆ t (θ) = E g t (X, θ)g ⊤ t (X, θ) and G t (β, u; θ) = E g t (X, θ)1 β ⊤ X ≤ u . The intuition behind (10) is very simple. First of all, note that, for each t ∈ T ,
is the vector of linear projection coefficients of regressing 1 β ⊤ X ≤ u on the score function g t (X, θ * ). Thus, it follows that
is the best linear predictor of 1 β ⊤ X ≤ u given g t (X, θ * ), and that (10) is nothing more than the associated projection error, which, by definition, is orthogonal to g t (X, θ * ). As a consequence of (10), it follows that, under some weak regularity conditions, uniformly
for each t ∈ T ; see Theorem 1 in the next section. Thus, R dpro n,t (β, u; θ n ) is asymptotically invariant to the choice of the estimator θ n . In addition, the second projection also facilitates a simple multiplier bootstrap method to simulate accurately critical values of test statistics based on R dpro n,t (β, u; θ n ). In order to operationalize our testing procedure, we need to choose a norm to measure the distance of R dpro n,t (·) from zero. We propose using the Cramér-von Mises-type test statistic CvM dpro n = t∈T a n (t)
where, for each t, a n (t) is a pre-specified (potentially random) non-negative weight function, F n,β (u) = n −1 n i=1 1 β ⊤ X i ≤ u is the empirical distribution function of the onedimensional projected regressors β ⊤ X i n i=1 for any fixed projected direction β ∈ S dx , and dβ is the rescaled uniform density on the unit sphere S dx . For the sake of practical convenience, in Monte Carlo simulations in Section 5 and Empirical application in Section 6, we simply use the constant weight a n (t) ≡ 1 for all t ∈ T , though other sensible choices are feasible, e.g., a n (t) = n −1 n i=1 1(T i = t). At this stage, one may wonder why we have chosen to use a Cramér-von Mises-type instead of a Kolmogorov-Sminov-type test statistic. The reason is computational: as we show below in Lemma 1, (11) can be written in a closed-form expression and does not rely on any type of numerical integration method. As a direct consequence of these attractive computational features is that (11) can be easily implemented even when X is high-dimensional.
Lemma 1 Let CvM dpro n be defined in (11) with S dx the d x -dimensional unit sphere.
Then, we have
CvM dpro n = t∈T a n (t) 1 n 2 n i=1 n j=1 n r=1 e pro i (t; θ n )e pro j (t; θ n )A ijr ,
with
and
where Γ (·) is the gamma function, arccos is the inverse cosine function, and
Lemma 1 yields an explicit formula for our double-projected test-statistic CvM dpro n . It builds on Escanciano (2006) and García-Portugués et al. (2014) , who derived expressions for Cramér-von Mises-type functionals of "single-projected" empirical processes akin to R pro n,t (β, u; θ n ). What is new in Lemma 1 is that it states that, instead of computing infinitely many projected residuals, one for each β ⊤ , u ⊤ ∈ Π pro as it is suggested by (9), it suffices to use the sequence of projected parametric residuals e pro i (t; θ n ), i = 1, . . . n, t ∈ T as defined in (13), which does not depend on β. Also, we note that in implementing (12), we can exploit the symmetry property A ijr = A jir , and that CvM dpro n = t∈T a n (t) 1 n 2ẽ
where A n = ( n r=1 A ijr ) i,j is an n × n matrix andẽ pro (t; θ n ) is the n × 1 vector of projected residuals, which further alleviates the computational cost (memory allocation) of our proposed procedure (see Section 3.2 of García-Portugués et al., 2014). These computational tricks substantially improve the computational time and allow one to apply our test to dataset with larger sample sizes. As we show in Section 4, they also help us on implementing an easy-to-use multiplier bootstrap to compute critical values.
3 Asymptotic results
Asymptotic null distribution
In this section we investigate the limiting behavior of double-projected residuals marked empirical process R dpro n,t (β, u; θ n ) under the null hypothesis H 0 in (5) and consequently that of test statistics CvM dpro n based on it. We list all the relevant regularity conditions as follows, which are standard. First, let us denote by F X (·) the marginal CDF of covariates X. Also, let Ψ pro (du, dβ) = F β (du)dβ. Recall that p t (x) = P(T = t|X = x), t ∈ T , are the generalized propensity scores.
Assumption 3 (i) The parameter space Θ is a compact subset of R q ; (ii) the true parameter θ * belongs to the interior of Θ; and (iii) the estimator θ n satisfies θ n − θ * = O p (n −1/2 ).
Assumption 4 The integrating function Ψ pro (·) is absolutely continuous with respect to the Lebesgue measure on Π pro .
To present our asymptotic results, henceforth, we adopt the following notation. For a generic set G, let l ∞ (G) be the Banach space of all uniformly bounded real functions on G, equipped with the uniform metric f G ≡ sup z∈G |f (z)|. We study the weak convergence of R dpro n,t (β, u; θ n ) and its related processes as elements of l ∞ (Π pro ), where Π pro ≡ S dx × [−∞, ∞] with S dx the unit ball in R dx . Let "⇒" denote weak convergence on (l ∞ (Π pro ) , B ∞ ) in the sense of J. Hoffmann-Jφrgensen, where B ∞ denotes the corresponding Borel σ-algebra -see e.g. Definition 1.3.3 in van der Vaart and Wellner (1996) .
The generalized error is defined as ε(t) = 1(T = t) − p t (X). The following theorem establishes the limiting null behavior of out test statistic CvM dpro n .
Theorem 1 Suppose Assumptions 1-4 hold. Then, under the null hypothesis H 0 in (5), for any sequence a n (t) = a(t)
To prove Theorem 1, we first show that the limiting null behavior of R dpro n,t (β, u; θ n ) does not depend on θ n nor how θ n is obtained. Based on this result, we simply combine the weak convergence of the doubly-projected empirical process R dpro n,t (·) with the continuous mapping theorem (see, e.g., van der Vaart and Wellner, 1996, Theorem 1.3.6) to derive the asymptotic distribution of our proposed Cramér-von Mises test statistic, CvM dpro n .
As is evident from Theorem 1, the asymptotic null distribution CvM dpro ∞ depends in a complicated manner on the underlying data generating process and thus critical values of CvM dpro ∞ are case-dependent. Thanks to the second projection introduced in R dpro n,t β, u; θ n (i.e., the orthogonal projection onto the tangent space of the nuisance parameters), we will be able to simulate as accurately as desired the critical values of CvM dpro ∞,J through a convenient multiplier bootstrap procedure, whose validity is guaranteed by Theorem 4 in Section 4.
Asymptotic power
In this section we study the asymptotic power properties of R dpro n,t (β, u; θ n ) under the fixed (i.e., global) alternative and a certain sequence of local alternatives converging to the null at the parametric rate. We first consider the fixed alternative hypothesis H 1 in (6).
Theorem 2 Suppose Assumptions 1-4 hold. Then, under the fixed alternative hypothesis H 1 in (6),
In Theorem 2, θ * should be understood as the limiting value of θ n , i.e., the pseudotrue parameter under H 1 in (6). It is also straightforward from Theorem 2 that under the fixed alternative H 1 , as long as the unconditional expectation
for some (β, u) and for some treatment level t ∈ T , CvM dpro n will diverge to positive infinity at the n rate, indicating that CvM dpro n is able to detect such fixed alternative with probability tending to one.
On the other hand, Theorem 2 indicates that CvM dpro n might not be consistent against all fixed alternative hypotheses in (6) 
Specifically, the test statistic cannot distinguish those alternatives such that, for every t ∈ T , the difference between p t (X) and q t (X, θ * ) is collinear to the score function g t (X, θ * ) associated with q t (X, θ * ). However, given the nonlinear nature of the generalized propensity score, we do not think this type of alternatives is of main practical concern. Indeed, such a concern can be mechanically eliminated by estimating θ * using nonlinear least squares.
We now proceed to consider the asymptotic local power properties of our proposed tests. Towards this end, we study the asymptotic distribution of R dpro n,t (β, u; θ n ) under a certain sequence of Pitman-type local alternatives converging to the null at a parametric rate. In particular, we consider the data generating process for the sequence of local alternatives given by
where, for each t ∈ T , the direction of departure from H 0 is given by function r t (X) (potentially different for each t), which is assumed to be F X (·)-integrable with zero mean and satisfy P (r t (X) = 0) < 1. Note that n −1/2 signifies the rate of H 1,n converging to H 0 as n increases, which is known as the fastest rate possible for specification tests to be able to non-trivially detect local alternatives.
Theorem 3 Suppose Assumptions 1-4 hold. Then, under the sequence of local alternatives H 1,n in (15), we have that
where R dpro ∞,t is the same Gaussian process as defined in Theorem 1, and δ t is a deterministic shift function given by
An immediate consequence of Theorem 3 is that, whenever there exists some t ∈ T such that the deterministic shift function δ t (β, u) = 0 for at least some (β, u) ∈ Π pro with a positive Lebesgue measure, our proposed Cramér-von Mises test statistic will have nontrivial power in detecting local alternatives of the form (15). A pathological situation in which our test will only have trivial local power against such alternatives is when r t (X) is a linear combination of score function g t (X, θ * ) for every treatment level t ∈ T , i.e., r t (X) = ν ⊤ g t (X, θ * ) a.s. for some nonzero vector ν. In such a case, the limiting distribution of CvM dpro n under H 0 and H 1,n is the same so that H 1,n cannot be detected. However, such a specific class of local alternatives is arguably of very limited practical interest.
A multiplier bootstrap procedure
Since the limiting null distribution of our test statistic CvM dpro n is non-pivotal, we propose a simple-to-implement multiplier bootstrap procedure to approximate the null distribution and show its asymptotic validity. Below is its implementation:
. . , n} is a sequence of independent and identically distributed random variables with mean zero and variance one; e.g. Rademacher random variables (Liu, 1988) or Bernoulli random variable with P (V = 1 − κ) = κ/ √ 5 and P (V = κ) = 1 − κ/ √ 5, where κ = 5 1/2 + 1 /2 (Mammen, 1993) .
Compute
3. Repeat steps 1 and 2 B times, and collect CvM dpro, * n b , b = 1 . . . , B .
4. Obtain the (1 − α)-th quantile of CvM dpro, * n b , b = 1 . . . , B , c * n,α , and set it as the critical value for the test with significance level α, for 0 < α < 1. (5) if CvM dpro n is greater than the critical value c * n,α , and fail to reject (5) otherwise.
Reject the null hypothesis
Note that CvM dpro, * n can be computed as
where A n is defined before andẽ pro, * (t; θ n ) is the n × 1 vector of e pro, *
. The multiplier bootstrapped test statistic CvM dpro, * n has attractive theoretical and empirical properties. First, it does not require computing new parameter estimates at each bootstrap draw, drastically reducing the computational intensity of the proposed procedure. Second, thanks to the use of the double-projections, its implementation does not require using estimators that admit an asymptotically linear representation. Third, thanks to the closed-form representation in (12), A ijr , which is the most expensive in computation time, does not need to be computed for each bootstrap sample. All these computational aspects are particularly important when either the dimensionality d x of the pre-treatment covariates X and/or the number of different treatment levels is large.
The next theorem establishes formally the asymptotic validity of the multiplier bootstrap procedure described above. Let
with V i as described in step 1 above. 
Theorem 4 states that the bootstrapped statistic CvM dpro, * n converges to the null limiting distribution of CvM dpro n conditional on the original sample. The fact that CvM dpro, * n has the same limiting distribution under H 0 , H 1 , and H 1,n is what allows the proposed procedure to work.
Remark 1 It is worth noting that, when the dependent variable is discrete (e.g., T i in our context of multi-valued treatment effects), the multiplier bootstrap is always meaningful as it does not require to generate bootstrap sample. On the other hand, in this particular context, the classical residual-based wild bootstrap such as the one used by Escanciano (2006) would generate bootstrapped dependent variables that are no longer discrete and thus fail to mimic the original data structures. A potential alternative to circumvent this drawback faced by the classical residual-based wild bootstrap is to use the parametric bootstrap, which, however, is much more computationally expensive because one needs to compute new parameter estimates at each bootstrap draw. When the number of covariates and/or the number of treatment levels is relatively high, such a procedure tends to be very time consuming.
Monte Carlo simulations
In this section, we conduct a series of Monte Carlo experiments to study the finite sample properties of the double projection-based tests in the context of observational treatment effect studies. We consider three different setups with (i) a binary treatment, (ii) multinomial, unordered treatments (henceforth multinomial treatments), and (iii) multinomial, ordered treatments (henceforth ordered treatments). For the sake of space, we defer the discussion of ordered treatments to Appendix B.
Given that the simulation results in Sant' Anna and Song (2019) indicate that their test dominate several others in terms of size and power in the binary treatment setup, we only compare our Cramér-von Mises tests CvM dpro n given in (12) to their Cramér-von Mises test. For the ordered and multinomial treatment setups, we consider extensions of the Sant'Anna and Song (2019)'s projection-based tests that are able to accommodate multi-valued treatment variables.
Critical values for the CvM dpro n test statistic are obtained using the multiplier bootstrap procedure described in Section 4, whereas for the single projection-based tests we use the multiplier bootstrap procedure described in Sant' Anna and Song (2019) . We consider sample sizes n equal to 200, 400, and 800. For each design, we consider 1, 000
Monte Carlo experiments. The {V i , i = 1, . . . , n} used in the bootstrap implementations are independently generated as V with P (V = 1 − κ) = κ/ √ 5 and P (V = κ) = 1−κ/ √ 5, where κ = √ 5 + 1 /2, as proposed by Mammen (1993) . The bootstrapped critical values are approximated using B = 999 bootstrap replications. In all simulations, we use constant weight a n (t) ≡ 1 for all t ∈ T in both CvM dpro n and CvM dpro, * n .
Simulation 1: Binary treatment
We first consider the binary treatment case with J = 1. Consider the following data generating processes (DGPs), which are similar to Sant'Anna and Song (2019):
For each of these five DGPs, T = 1 {T * > 0} , ε ⊥ ⊥ X, with X = (1, X 1 , X 2 , . . . , X 10 ) ⊤ where X 1 = Z 1 , X 2 = (Z 1 + Z 2 ) / √ 2, X k = Z k , k = 3, . . . , 10, and {Z k } 10 k=3 and ε are independent standard normal random variables. For each of these DGPs we consider the following potential outcomes:
where m 1 (X) = 1 + 10 j=1 X j , u (1) and u (0) are independent normal random variables with mean zero and variance 1. The observed outcome is Y = T Y (1)+(1 − T ) Y (0), and the true average treatment effect (AT E) is 1. Although these outcome equations are not necessary to assess the size and power properties of the tests, they can be used to assess the utility of our proposed tests to distinguish between "good" and "bad" estimates of the AT E.
For DGP 1 − DGP 5, the null H 0 considered is
where Φ(·) is the CDF of the standard normal distribution. We estimate θ * using the probit maximum likelihood, i.e.,
Clearly, DGP 1 falls under H 0 , whereas DGP 2−DGP 5 fall under H 1 , i.e., the negation of (16). Note that the treatment status T follows a heteroskedastic probit model in DGP 5.
We compare the performance of our proposed test statistic CvM dpro n in (12) based on double projections with Sant'Anna and Song (2019)'s Cramér-von Mises test
. The simulation results are presented in Table 1 . We report empirical rejection frequencies at the 5% significance level. Results for 10% and 1% significance levels are similar and are available upon request. We also report the bias, root mean squared error (RMSE), and coverage of the 95% confidence interval of the stabilized inverse probability weighted estimator
where w i,1 = T i /q X i , θ n , w i,1 = (1 − T i ) / 1 − q X i , θ n , andw n,t is the sample mean of w i,t for t = 0, 1. The 95% confidence interval is estimated via the percentile bootstrap with 499 draws. We first analyze the size of our test. From the results of DGP 1, we find that the actual finite sample size of both CvM dpro n and CvM ss n tests is close to their nominal size, even when the sample size is as small as 200. In addition, note that when the propensity score is correctly specified, the bias of the AT E n estimator in (18) is small, and the coverage probability is close to its nominal value even when n = 200.
Note that when the propensity score is misspecified in DGP 2-DGP 5, the AT E estimator (18) can be severely biased and its 95% confidence interval too liberal, i.e., it can severely undercover the true AT E. Thus, tests with higher power to detect such model misspecifications can prevent one to make misleading conclusions about the effectiveness of a given policy. Our proposed CvM dpro n test perform admirably well in such a task. Perhaps, what is more important to emphasize in terms of power is that in all alterna- (17). Finally, "Bias", "RMSE" and "COV" stand for the average simulated bias, average simulated root mean squared error, and 95% coverage probability for the AT E estimator AT E n as defined in (18) 
Simulation 2: Multinomial treatments
In this section we consider unordered, multinomial treatments. Our DGPs are similar to Yang et al. (2016) . The covariates X 1 , X 2 , X 3 are generated from a multivariate normal distribution with mean zero, variances of (2, 1, 1) and covariances of (1, −1, −0.5); X 4 follows a uniform distribution from −3 to 3; X 5 follows a chi-squared distribution with one degree of freedom; and X 6 follows a Bernoulli distribution with p = 0.5. Let X = (X 1 , . . . , X 6 ) ⊤ . We consider three treatment groups, T = {0, 1, 2}, whose assignment mechanism follows the multinomial logistic model
where T t is the treatment indicator, i.e., T t = 1 (T = t), and for t = 0, 1, 2,
.
In what follows, we take φ 0 (X) = 0 and vary φ 1 (X) and φ 2 (X) as follows:
For each of these DGPs we consider the potential outcomes
where u (0), u (1) and u (2) are independent normal random variables with mean zero and variance 1, β 0 = (−6, −6, −6, 6, 6, 6) ⊤ , β 1 = −β 0 , and β 2 = 4. The observed outcome is Y = 1 (T = 0) Y (0) + 1 (T = 1) Y (1) + 1 (T = 2) Y (2), and the true AT E 1,0 = 1, AT E 2,0 = 2, and AT E 2,1 = 1. Let α = (α 1 , α 2 ) ⊤ and δ = δ ⊤ 1 , δ ⊤ 2 ⊤ . For DGP 6 − DGP 0, the H 0 considered is
where, with some abuse of notation, we set α 0 = δ 0 = 0. We estimate θ * using the multinomial logit likelihood, i.e.
Clearly, DGP 6 falls under H 0 , whereas DGP 7 − DGP 10 fall under H 1 , i.e., the negation of (19).
In the multinomial setup, our proposed test statistic CvM dpro n is given by (12) with a n (1) = a n (2) = 1, e i t; θ n = 1 (T i = t) − q t X i , θ n , 
where, for t = 1, 2, CvM ss1,m
g t (X, θ) and ∆ −1 n,t (θ) being defined as before, and 
where, for t = 1, 2, CvM ss2,m
, and g t (x, θ), G n,t (u, θ) and ∆ n,t (θ) defined analogously to the binary treatment setup.
It is important to emphasize that (20) and (21) 
, Λ m 2 (X, θ * )] = 0 a.s. for t = 0, 1.
whereas (21) is a test statistic based on the null hypothesis (6).
The simulation results are presented in Table 2 . We report empirical rejection frequencies at the 5% significance level. We also report the bias, RMSE, and coverage of the 95% confidence interval of the stabilized inverse probability weighted estimators
where
andw n,t is the sample mean of w i,t , t = 0, 1, 2. The 95% confidence interval is estimated via the percentile bootstrap with 499 draws. (20) and (21), respectively. Finally, "Bias k,s ", "RM SE k,s " and "COV k,s " stand for the average simulated bias, average simulated root mean squared error, and 95% coverage probability for the AT E k,s estimator AT E n,k,s as defined in (22). The 95% coverage probability is based on the percentile bootstrap with 499 draws. See the main text for further details.
As before, we first discuss the size properties of the tests. From the results of DGP 6, we find that all considered tests have good size properties and the IPW estimators for the average treatment effects have little to no bias, their RMSE decrease with sample size, and their coverage probability is very close to the nominal level.
In terms of power, note that, under DGP 7-10, our proposed double-projection test Overall, our simulation results highlight that the proposed projection-based tests perform favorably compared to other alternative testing procedures. Importantly, the simulations illustrate that our proposed tests are suitable to setups with many covariates, and that the gains in power when compared to other alternatives can be substantial. Given these attractive features, we believe that our tests can be of great use in practice.
Data illustration
In this section, we apply our tests to analyze the goodness-of-fit of different generalized propensity score models used to study the effect of maternal smoking on birth weight. The dataset, available at http://www.stata-press.com/data/r13/cattaneo2.dta, is the excerpt from Almond et al. (2005) and Cattaneo (2010) previously used by Lee et al. (2017) . It consists of observations from white mothers in Pennsylvania in the USA; like Lee et al. (2017) , we further restrict our sample to white and non-Hispanic mothers, totally 3, 754 observations. The treatment variable, T , is a multi-valued variable that is equal to 0 if the mother does not smoke during the pregnancy, equal to 1 if the mother smokes, on average, between one and five cigarettes a day during the pregnancy, equal to 2 if the mother smokes, on average, between six and ten cigarettes a day during the pregnancy, and equal to 3 if the mother smokes, on average, more than eleven cigarettes a day during the pregnancy. The set of pre-treatment covariates X we use are mother's age, number of prenatal care visits, and indicator variables for alcohol consumption during pregnancy, first prenatal visit in the first trimester, whether there was a previous birth where the newborn died, twelve years of education (complete high-school), and more than twelve years of educations (some college). The outcome of interest is the infant birth weight measured in grams. We start our analysis by analyzing the effect of the mother being a smoker during the pregnancy (T > 0) versus not smoking during the pregnancy (T = 0). Given the binary nature of the "being a smoker" treatment, we estimate the propensity score using a logistic regression model with linear predictors including all aforementioned covariates.
We then apply our proposed specification test to assess the goodness-of-fit of this simple propensity score model, using 9, 999 bootstrap replications. Our procedure yields a pvalue of 0.18, suggesting that our proposed testing procedure does not find any evidence of model misspecification at the usual significance levels. Next, we move our attention to analyzing the effect of maternal smoking intensity during pregnancy, T . Given that the treatment T is clearly ordered, we estimate the 
-279 39 (-357, -202) (c) The causal effect of mother's smoking intensity during pregnancy on infant's birth weight Estimators based on a multinomial logit generalized propensity score model
-267 42 (-347, -184) Note: Standard errors computed using the empirical bootstrap with 9,999 draws. 95% confidence intervals based on the percentile bootstrap with 9,999 draws. See the main text for further details.
generalized propensity score using an ordered logit regression model with all covariates entering the model in a linear fashion. Although natural, we note that the ordered logit model imposes important restrictions on the data such as a proportional odds restriction. In practice, however, such restrictions may be too rigid for a given application. Indeed, our proposed specification test with 9, 999 bootstrap replications yield a p-value of 0.08, suggesting that the ordered logit model is misspecified at the 10% significance level. A relatively straightforward way to relax the proportional odd restrictions inherited in the ordered logit model is to ignore that the treatment T is ordered and estimate the generalized propensity score using a multinomial logit linear regression model. In contrast with the ordered logit model, the multinomial logit model does not impose that the regressors coefficients are the same across different treatment levels. Our specification test with 9, 999 bootstrap replications yield a p-value of 0.72, suggesting that the multinomial logit model is a more suitable model for maternal smoking intensity during pregnancy T than the order logit model. Table 3 shows the estimates of the causal effects of smoking on birth weight based on the inverse probability weighting estimators for binary and multi-valued treatments, AT E n as in (18) and AT E n,j,ℓ as in (22), respectively. Although qualitatively similar, one can notice some differences on the standard errors and confidence intervals between the treatment effects estimates based on misspecified ordered logit model and those based on the multinomial logit model for the generalized propensity score. This illustrates one of the potential pitfalls of model misspecification.
Conclusion
In this article, we proposed a new class of specification tests for generalized propensity score models based on a novel double-projected weight functions. We have shown that the use of double projections helps ameliorate the "curse of dimensionality" and avoids the complications associated with "parameter estimation uncertainty" commonly encounter in specification testing with moderate or high-dimensional covariates. We have also shown that our proposed test statistics can be written in closed-form, and that one can use an easy-to-implement multiplier bootstrap procedure to compute critical values as accurately as desired. The simulation results and the empirical application highlight that our proposed tests can serve as a valuable diagnostic tool in the context of multivalued treatment effects.
Although we focused on the generalized propensity score models, we note that our proposed methodology can be readily used in other contexts, too. For instance, one can use our double-projection procedure to test if a given parametric regression model is correctly specified, i.e., to test
where m(X) = E [Y |X] is the true regression function, and f (X, θ) is a parametric specification for m(X). We also anticipate that one can extend our proposal to test whether a putative (nonlinear) quantile or distribution regression are correctly specified; see, e.g., Rothe and Wied (2013) and Escanciano and Goh (2014) . We leave a detailed analysis of this extension for future research.
Appendix A: Mathematical proofs
Proof of Lemma 1: For simplicity, let us consider J = 1 (the binary treatment case) and thus omit the dependence on t. The general case with J ≥ 2 follows readily. First, recall the definition of projection operator P n 1 β ⊤ X i ≤ u . By simple algebra,
As in Escanciano (2006) 
where the second equality follows by letting j = s, and
where the second equality follows by letting i = s and j = t. As a result,
This completes the proof of Lemma 1.
The proof of Theorem 1 is very similar to the proofs of Theorem 1 and Corollary 1 in Sant' Anna and Song (2019) . For the sake of completeness, in the following we give its proof. Towards this end, we first need to introduce several auxiliary lemmas. The next lemma establishes the uniform asymptotic decomposition of the "once" projected empirical process
Lemma A.1 Suppose Assumptions 1-3 hold. Then, for each t ∈ T , we have that
Proof of Lemma A.1: Observe that, for each t,
By the Mean Value Theorem (MVT) and Assumptions 2-3, the second term in the previous expression is simply
with θ n lying between θ n and θ * , where the latter equality follows by the uniform law of large numbers (ULLN) of Newey and McFadden (1994, Lemma 2.4) . This finishes the proof of Lemma A.1. Now, for each t ∈ T , introduce the following auxiliary quantity,
Lemma A.2 Suppose Assumptions 1-3 hold. Then, under the null hypothesis H 0 in (5), for each t ∈ T , we have that
where ∆ t (θ) = E g t (X, θ)g ⊤ t (X, θ) .
Proof of Lemma A.2:
We can rewrite S n,t as
We first show that S 1n,t = − √ n( θ n − θ * ) ⊤ ∆ t (θ * ) + o p (1). To this end, note that
with θ n lying between θ n and θ * , where the second equality follows by the MVT, and the last equality follows from the ULLN of Newey and McFadden (1994, Lemma 2.4) , and Assumptions 2-3. It thus remains to show that both S 2n,t and S 3n,t are asymptotically negligible. First note that
with θ n lying between θ n and θ * , where the first equality follows by MVT, the second equality by ULLN of Newey and McFadden (1994, Lemma 2.4) , and the last equality by Assumptions 2-3 as well as the law of iterated expectations (LIE) under the null hypothesis H 0 . For the last term S 3n,t , we have
with θ n andθ n both lying between θ n and θ * , where the second equality follows by MVT, the third equality by ULLN of Newey and McFadden (1994, Lemma 2.4) , and the last equality by Assumptions 2-3. Thus, S 3n,t = O p (n −1/2 ) = o p (1). This ends the proof of Lemma A.2.
The next two lemmas establish the uniform convergence of G n,t (β, u; θ n ) and ∆ −1 n,t ( θ n ) to G t (β, u; θ * )and ∆ −1 t (θ * ), respectively.
Lemma A.3 Suppose Assumptions 1-3 hold. Then, for each t ∈ T , we have that
Proof of Lemma A.3: The proof follows directly from the ULLN ofNewey and McFadden (1994, Lemma 2.4) .
Lemma A.4 Suppose Assumptions 1-3 hold. Then, for each t ∈ T , we have that
Proof of Lemma A.4: The proof follows from the ULLN of Newey and McFadden (1994, Lemma 2.4 ) and the continuous mapping theorem.
With the help of Lemmas A.1-A.4, we are ready to proceed with the proofs of our main theorems.
Proof of Theorem 1:
We first establish the uniform asymptotic representation of R dpro n,t (β, u; θ n ), which states that R dpro n,t (β, u; θ n ) is asymptotically invariant to θ n . Based on the representation, we prove the weak convergence of R dpro n,t (β, u; θ n ). Lastly, the limiting null distribution of CvM dpro n can be obtained by standard techniques. By a straightforward decomposition, we have
Then, by Lemmas A.1-A.4, we have that R dpro n,t (β, u; θ n )
and consequently the weak convergence of R dpro n,t (β, u; θ n ) to the centered Gaussian process R dpro ∞,t with covariance structure K dpro t ((β, u) , (β ′ , u ′ )) specified in (14) can be readily obtained by showing that the finite-dimensional distributions of R dpro n0,t (β, u; θ * ) converge to those of R dpro ∞,t and the stochastic equicontinuity of R dpro n0,t (β, u; θ * ) by a straightforward application of Donsker property of the class of linear indicator functions F =
For the convergence in distribution of test statistic CvM dpro n , we will prove that t∈T a n (t)
Given the assumption that a n (t) p − → a(t) for each t ∈ T , according to Slutsky's theorem, it suffices to show that, for each t ∈ T ,
First of all, note that the weak convergence of the double-projected process R dpro n,t (β, u; θ n ) and the Skorohod construction [see, e.g., Serfling, 1980] 
Note that the empirical distribution function F n,β (u) ≡ n −1 n i=1 1 β ⊤ X i ≤ u estimates CDF F β (u) := P β ⊤ X ≤ u a.s. uniformly for (β, u) ∈ Π pro by invoking the ULLN of Jennrich (1969) or the generalization by Wolfowitz (1954) of the Glivenko-Cantelli theorem. That is, sup
The first term of the right-hand side of the above inequality is o(1) a.s. due to (A.2). The trajectories of the limiting process R dpro ∞,t (β, u) are bounded and continuous a.s.. Then, by applying the Helly-Bray Theorem (see p. 97 in Rao, 1965) to each of these trajectories and taking into account (A.3), we have that the second term of the right-hand side of the above inequality is also o(1) a.s.. This concludes the proof of Theorem 1.
Proof of Theorem 2: Under Assumptions
by ULLN of Newey and McFadden (1994, Lemma 2.4 ) and similar arguments in proving Lemmas A.1, A.3 and A.4.
Proof of Theorem 3:
Note that under the local alternatives H 1,n in (15), we have that uniformly in (β, u) ∈ Π pro :
where the second equality follows by similar arguments in proving Theorem 1 and by ULLN. Since e i (t; θ * ) − n −1/2 r t (X i ) forms a zero mean and i.i.d. summand in this local alternative framework, we can apply the functional central limit theorem to R dpro n1,t (β, u; θ * ) by checking the finite-dimensional distributions of R dpro n1,t (β, u; θ * ) and its stochastic equicontinuity, just as we applied it to R dpro n0,t (β, u; θ * ) defined in (A.1). This leads to R dpro n1,t (β, u; θ * ) ⇒ R dpro ∞,t . The last step thus follows and we finish the proof of Theorem 3.
Proof of Theorem 4: As in Theorem 1, we have the following decomposition:
Conditional on the original sample, it follows from a stochastic equicontinuity (or MVT) argument and the consistency of θ n to θ * that, uniformly in (β, u) ∈ Π pro , R pro, * n,t (β, u; θ n ) 
leading to the multiplier bootstrapped version of R dpro n0,t (β, u; θ * ) defined in (A.1). Recall the properties of the sequence of multipliers {V i } n i=1 . The rest of the proof then follows readily from the multiplier central limit theorem applied to the (infeasible) multiplier bootstrapped double-projected process R dpro, * n0,t (β, u; θ * ) regardless whether the null hypothesis holds or not (see van der Vaart and Wellner, 1996, Theorem 2.9.2, p. 179) , and the continuous mapping theorem.
Appendix B: Simulation exercise for ordered treatments
In this section we consider ordered, multinomial treatments with J = 2. Specifically, we consider three treatment groups, T = {0, 1, 2}, whose assignment mechanisms are given by the following conditional distributions:
where Λ (·) is the logistic CDF, i.e., Λ (a) = exp (a) / (1 + exp (a)), α 1 > α 0 , and of course, P (T ≤ 2|X) = 1 a.s. 1 . We vary φ (X), γ (X) and α t as following:
DGP 11. φ (X) = − 10 j=1 X j 8 , γ (X) = 1, α 0 = −1, α 1 = 0.5.
DGP 13. φ (X) = − 10 j=1 X j 10 + X 1 5 k=2 X k 2 , γ (X) = 1, α 0 = 0, α 1 = 1.5;
DGP 14. φ (X) = − 10 j=1 X j 6 + 10 k=1 X 2 k 10 , γ (X) = 1, α 0 = 0, α 1 = 1.5;
1 The scaling constant π/ √ 3 is to make the generalized propensity score coefficients comparable to those used in Section 5.1, where we adopt a Gaussian link function instead of a logistic link function as we do here. For each of these five DGPs, X = (X 1 , X 2 , . . . , X 10 ) ⊤ with {X j } 10 j=1 defined as in §5.1. For each of these DGPs we consider the following potential outcomes:
where u (0), u (1) and u (2) are independent normal random variables with mean zero and variance 1, β 0 = (−4, −4, −4, −4, −4, 4, 4, 4, 4, 4) ⊤ , β 1 = −β 0 , and β 2 = 3. The observed outcome is Y = 1 {D = 0} Y (0) + 1 {D = 1} Y (1) + 1 {D = 2} Y (2), and the true AT E 1,0 = 1, AT E 2,0 = 2, and AT E 2,1 = 1.
For DGP 6 − DGP 10, the H 0 considered is H 0 : ∃θ * = α 0 , α 1 , δ ⊤ 0 ⊤ ∈ Θ : P (T ≤ t|X) = Λ α t − X ⊤ δ 0 a.s. for t = 0, 1. (B.1)
We estimate θ * using the ordered logit (proportional odds) likelihood, i.e., θ n = arg max (α0,α1,δ ⊤ )
where, with some abuse of notation, α −1 ≡ −∞ and α 2 ≡ +∞. Clearly, DGP 11 falls under H 0 , whereas DGP 12 − DGP 15 fall under H 1 , i.e., the negation of (B.1). Note that DGPs in the ordered treatment setup resemble those in the binary setup described in Section 5.1. In the ordered setup, our proposed test statistic CvM dpro n is given by (12) with e i t; θ n = 1 (T i ≤ t)−Λ α n,t − X ⊤ i δ n , and the score function defined accordingly. That is, we use (12) with weight a n (t) ≡ 1 for every t and n. Although Sant'Anna and Song (2019) only considered specification tests for binary treatments, we note that their tests can be extended to test (B.1) by using the following test statistic: q t X i , θ n 2 , q t X i , θ n = Λ α n,t − X ⊤ i δ n , e j (t; θ n ) = 1 (T j ≤ t) − q t X j , θ n , R ss,o n,t (u) ≡ 1 √ n n j=1 e j (t; θ n )P n,t 1 q t X j , θ n ≤ u , with projection-based weights given by P n,t 1 (q t (X, θ) ≤ u) = 1 (q t (X, θ) ≤ u) − g ⊤ t (X, θ)∆ −1 n,t (θ) G n,t (u, θ) , (B.3) and g t (x, θ), G n,t (u, θ) and ∆ n,t (θ) defined analogously to the binary treatment setup. It is important to emphasize that (B.2) is a test statistic for an implication of (B.1), i.e., (B.2) is a test statistic for the following null hypothesis:
H ′ 0 : ∃θ * = α 0 , α 1 , δ ⊤ 0 ⊤ ∈ Θ : E e(t; θ * )|Λ α t − X ⊤ δ 0 = 0 a.s. for t = 0, 1, where e(t; θ * ) = 1(T ≤ t) − Λ α t − X ⊤ δ 0 . Thus, although CvM ss,o n,t also avoids the "curse of dimensionality", we cannot ensure its consistency against general nonparametric alternatives H 1 , only against H ′ 1 , the negation of H ′ 0 2 . The statistic CvM dpro n,t thus is always preferred to.
The simulation results are presented in Table B .1. As it is evident from Table B .1, our proposed double-projected test, CvM dp,ord n , and the extension of Sant'Anna and Song (2019)'s test, CvM ss,o n , have finite sample size close to their nominal size. Furthermore, when the generalized propensity score is correctly specified, all IPW estimators for the average treatment effects have little to no bias, their RMSE reduces with sample size, and their coverage probability is very close to its nominal level.
Under model misspecifications as in DGP 12 − DGP 15, the IPW estimators (22) are biased for the true average treatment effects and, in general, such biases do not reduce with sample size. In addition, inference procedures for the treatment effects can be unreliable. Thus, detecting generalized propensity score misspecifications can prevent misleading inference about the causal effect of interest. As in the binary setup, our proposed test CvM dpro n performs remarkably well and strictly dominate CvM ss,o n in all considered DGPs. For instance, for DGP 12 with n = 200, CvM dpro n is eight times more powerful than CvM ss,o n ; for DGP 13 with n = 200, CvM dpro n rejects (B.1) more than four times more often than CvM ss,o n . As mentioned before, part of this gain of power can be credited to the fact that CvM ss,o n may have trivial power against some directions and this can have important practical consequences. On the other hand, CvM dpro n is consistent against all nonparametric (fixed) alternatives, highlighting its potential attractiveness.
2 Given the ordered nature of the treatment assignment, we know that the sigma algebra generated by Λ α 0 − X ⊤ δ 0 , Λ α 1 − X ⊤ δ 0 is equivalent to the sigma algebra generated by Λ α t − X ⊤ δ 0 , t = 0, 1, implying that we can rewrite H ′ 0 as H ′ 0 : ∃θ 0 = (α 0 , α 1 , δ ⊤ 0 ) ⊤ ∈ Θ : E e(t; θ 0 )|Λ α t − X ⊤ δ 0 , Λ α 1 − X ⊤ δ 0 = 0 a.s. for t = 0, 1.
Thus, in the ordered treatment setup, augmenting the conditioning set to Λ α 0 − X ⊤ δ 0 , Λ α 1 − X ⊤ δ 0 does not affect the power properties of CvM ss,o n . (12). "CvM ss,o n " stands for the extension of Sant'Anna and Song (2019)'s test defined in (B.2). Finally, "Bias k,s ", "RM SE k,s " and "COV k,s " stand for the average simulated bias, average simulated root mean squared error, and 95% coverage probability for the AT E k,s estimator AT E n,k,s as defined in (22). The 95% coverage probability is based on the percentile bootstrap with 499 draws. See the main text for further details.
